<HashMap><database>biostudies-literature</database><scores/><additional><submitter>van den Dijssel J</submitter><funding>University of Melbourne</funding><funding>Australian Research Council</funding><funding>Sanquin Blood Supply Project Grant</funding><pagination>e202451565</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11898545</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(3)</volume><pubmed_abstract>Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections. Cytomegalovirus (CMV) infection results in declining naïve (T&lt;sub>naïve&lt;/sub>) and increasing terminally differentiated (T&lt;sub>emra&lt;/sub>) T cell populations, further aggravating immune aging. Both immunosenescence and CMV have been speculated to hamper the formation of protective T-cell immunity against novel or emerging pathogens. The SARS-CoV-2 pandemic presented a unique opportunity to examine the impact of age and/or CMV on the generation of de novo SARS-CoV-2-specific CD8&lt;sup>+&lt;/sup> T cell responses in 40 younger (22-40 years) and 37 older (50-66 years) convalescent individuals. Heterotetramer combinatorial coding combined with phenotypic markers were used to study 35 SARS-CoV-2 ep</pubmed_abstract><journal>European journal of immunology</journal><pubmed_title>Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T Cell Responses.</pubmed_title><pmcid>PMC11898545</pmcid><funding_grant_id>PPOC / L2506</funding_grant_id><funding_grant_id>EstablishmentGrant</funding_grant_id><funding_grant_id>ARC-DECRA Fellowship / DE220100185</funding_grant_id><pubmed_authors>van de Sandt CE</pubmed_authors><pubmed_authors>Raaphorst H</pubmed_authors><pubmed_authors>Turksma AW</pubmed_authors><pubmed_authors>Veldhuisen B</pubmed_authors><pubmed_authors>van den Dijssel J</pubmed_authors><pubmed_authors>Koets L</pubmed_authors><pubmed_authors>Ten Brinke A</pubmed_authors><pubmed_authors>van Lier RAW</pubmed_authors><pubmed_authors>van Ham SM</pubmed_authors><pubmed_authors>de Jongh R</pubmed_authors><pubmed_authors>Freen-van Heeren JJ</pubmed_authors><pubmed_authors>Steenhuis M</pubmed_authors><pubmed_authors>Konijn VAL</pubmed_authors><pubmed_authors>Duurland MC</pubmed_authors><pubmed_authors>van der Schoot CE</pubmed_authors><pubmed_authors>van Gisbergen KPJM</pubmed_authors><pubmed_authors>Rispens T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T Cell Responses.</name><description>Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections. Cytomegalovirus (CMV) infection results in declining naïve (T&lt;sub>naïve&lt;/sub>) and increasing terminally differentiated (T&lt;sub>emra&lt;/sub>) T cell populations, further aggravating immune aging. Both immunosenescence and CMV have been speculated to hamper the formation of protective T-cell immunity against novel or emerging pathogens. The SARS-CoV-2 pandemic presented a unique opportunity to examine the impact of age and/or CMV on the generation of de novo SARS-CoV-2-specific CD8&lt;sup>+&lt;/sup> T cell responses in 40 younger (22-40 years) and 37 older (50-66 years) convalescent individuals. Heterotetramer combinatorial coding combined with phenotypic markers were used to study 35 SARS-CoV-2 ep</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-04T09:07:36.449Z</modification><creation>2025-04-04T09:07:36.449Z</creation></dates><accession>S-EPMC11898545</accession><cross_references><pubmed>40071711</pubmed><doi>10.1002/eji.202451565</doi></cross_references></HashMap>